The Future Of Cannabis: ‘A Tremendous Amount Of Upside’ Despite Challenges Says Curaleaf Executive
As the cannabis industry eagerly watches for changes to federal regulations, Boris Jordan, executive chairman of Curaleaf, weighed in on how potential rescheduling could reshape both the U.S. and international cannabis markets. During his interview at the Benzinga Cannabis Capital Conference, Jordan shared his thoughts on how the evolving regulatory landscape could impact Curaleaf’s expansion and the broader cannabis industry.
The Impact of Federal Rescheduling
Jordan emphasized the positive effects that federal rescheduling would have on Curaleaf’s operations in the U.S. and globally. “Any change, positive change in the U.S., always helps business, whether in the U.S. or internationally,” he said. For example, a shift to Schedule III would allow Curaleaf to unlock more capital for its domestic and international investments. “Schedule III would allow us to free up more cash to invest in both the U.S. and international businesses,” Jordan noted.
The timing of regulatory developments could be crucial for …